Opicapone in Parkinson's Disease on Levodopa‐Carbidopa Intestinal Gel Treatment: A Pilot, Randomized Study

Documenti analoghi

• Risk‐Benefit Considerations in Deep Brain Stimulation Discontinuation for Late‐Stage Parkinson's Disease
  di: Pietro Antenucci, et al.
  Pubblicazione: (2026)
• Levodopa/Carbidopa Intestinal Gel ( LCIG ) Treatment in a Patient with Parkinson's Disease and Hemophilia A
  di: Petra Havránková, et al.
  Pubblicazione: (2026)
• Levodopa‐Carbidopa Intestinal Gel in an Outpatient Setting: A 10‐Year Experience
  di: Alessandro Magliozzi, et al.
  Pubblicazione: (2025)
• Levodopa‐Carbidopa Intestinal Gel Improves Dyskinesia in Parkinson's Disease: Post Hoc Analysis from the COSMOS Study
  di: Alfonso Fasano, et al.
  Pubblicazione: (2025)
• The Benefit of Exclusive Nocturnal Levodopa‐Carbidopa Intestinal Infusion for Severe Refractory Sleep Behavior Disorder in Parkinson's Disease
  di: María Rivera‐Sánchez, et al.
  Pubblicazione: (2025)